Entity/Public Space Stock Epinephrine

Stock epinephrine is rapidly moving beyond the school walls and out to public venues – from theme parks, restaurants and sports arenas to daycare centers and more.

Thirty-one states have now passed what are called “entity laws” (as of September 20, 2017), legislation that permits venues to maintain an epinephrine auto-injector, with the intention of reducing the time it takes to get lifesaving epinephrine to a person having a sudden anaphylactic reaction.  

States colored yellow on the map below have entity legislation that has been introduced into the state legislature and referred to committee for consideration in the current or upcoming session.

States colored red are without entity legislation.

Click on the state listings below to read the legislation.

Entity-Epinephrine-legis 9-20-17

 

 Green states:  Yellow states:  Red states:
Alaska Delaware Connecticut
Alabama District of Columbia Hawaii
Arkansas Illinois Kansas
Arizona Pennsylvania Louisiana
California Vermont Maryland
Colorado Virginia Massachusetts
Florida Mississippi
Georgia Montana
Idaho Nebraska
Indiana New Mexico
Iowa North Dakota
Kentucky
South Dakota
Michigan Texas
Minnesota Wyoming
Missouri
Maine
Nevada
New Hampshire
New Jersey
New York
North Carolina
Ohio
Oklahoma
Oregon
Rhode Island
South Carolina
Tennessee
Utah
Washington
West Virginia
Wisconsin

For questions and to get involved in Entity Legislation in your state, contact Charmayne Anderson at canderson@allergyasthmanetwork.org or 800.878.4403.